These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9863141)

  • 1. Effect of procainamide on pulmonary thromboembolism and platelet malondialdehyde in mice.
    Pang JX; Sun LS; Wang XY; Yang SQ; Shan CW
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):500-2. PubMed ID: 9863141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of danshen injection on pulmonary thromboembolism and platelet free radical levels in mice].
    Wang X; Pang J; Shan C; Yang S; Zheng Y
    Zhongguo Zhong Yao Za Zhi; 1996 Sep; 21(9):558-60, inside back cover. PubMed ID: 9772649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of procainamide on rabbit platelet aggregation and thromboxane B2 production in vitro.
    Shan CW; Lin JH; Jin YH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):164-6. PubMed ID: 10374644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vintoperol on platelet aggregation and experimental thrombosis.
    Csomor K; Kárpáti E
    Arzneimittelforschung; 1994 Jan; 44(1):36-40. PubMed ID: 8135876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of procainamide on ultrastructure of blood platelet in rabbits.
    Liu LP; Shan CW; Liu XH; Xiao HC; Yang SQ
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):376-9. PubMed ID: 10375789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension.
    Hernández-Hernández R; Armas-Padilla MC; Velasco M; Carvajal AR; Armas de Hernández MJ; Guerrero-Pajuelo J; Pacheco B
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):323-31. PubMed ID: 10442506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature.
    Emerson M; Momi S; Paul W; Alberti PF; Page C; Gresele P
    Thromb Haemost; 1999 Jun; 81(6):961-6. PubMed ID: 10404776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats.
    Qu YZ; Li XX
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies.
    Hsiao G; Lee JJ; Lin KH; Shen CH; Fong TH; Chou DS; Sheu JR
    Cardiovasc Res; 2007 Sep; 75(4):782-92. PubMed ID: 17560560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effect of the type III collagen-related octapeptide (KOGEOGPK) in the mouse.
    Maurice P; Pires V; Amant C; Kauskot A; Da Nascimento S; Sonnet P; Rochette J; Legrand C; Fauvel-Lafeve F; Bonnefoy A
    Vascul Pharmacol; 2006 Jan; 44(1):42-9. PubMed ID: 16269270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro.
    Alarayyed NA; Prichard BN; Betteridge DJ; Smith CC
    Platelets; 2002; 13(5-6):267-71. PubMed ID: 12189011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardamom extract as inhibitor of human platelet aggregation.
    Suneetha WJ; Krishnakantha TP
    Phytother Res; 2005 May; 19(5):437-40. PubMed ID: 16106388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pulmonary accumulation of 51chromium-labelled rat platelets following intravenous application of ADP and collagen.
    Klee A; Seiffge D
    Thromb Haemost; 1991 May; 65(5):588-95. PubMed ID: 1871721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of buflomedil on epinephrine-enhanced platelet aggregation in vitro and ex vivo.
    Wurzinger LJ; Schmid-Schönbein H
    Arzneimittelforschung; 1987 Oct; 37(10):1113-5. PubMed ID: 3435582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro.
    Pierre S; Crosbie L; Duttaroy AK
    Platelets; 2005 Dec; 16(8):469-73. PubMed ID: 16287614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation, malondialdehyde generation and production time in children with sickle cell anaemia.
    Buchanan GR; Holtkamp CA
    Thromb Haemost; 1981 Dec; 46(4):690-3. PubMed ID: 7330819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malondialdehyde production by platelets during secondary aggregation.
    MacFarlane DE; Gardner S; Lipson C; Mills DC
    Thromb Haemost; 1977 Dec; 38(4):1002-9. PubMed ID: 579680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
    Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
    Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of certain antiplatelet drugs on in vitro malonylaldehyde (MDA) production.
    Fabris F; Casonato A; De Marco L; Girolami A
    Arzneimittelforschung; 1979; 29(7):981-3. PubMed ID: 583000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.